DIVI S LABORATORIES LTD vs LUPIN LIMITED

A side-by-side comparison of DIVI S LABORATORIES LTD (DIVISLAB) and LUPIN LIMITED (LUPIN) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, LUPIN LIMITED leads DIVISLAB vs LUPIN on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

74.93
P/E ratio
20.94
10.72
P/B ratio
4.89
0.44%
Dividend yield
0.72%
₹96.73
EPS
₹116.65

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

16.50%
Return on equity
29.10%
22.00%
Return on capital
30.00%
33.00%
EBITDA margin
32.00%
24.32%
Net margin
19.15%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
18.88%
12.10%
Profit CAGR (3Y)
128.64%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.92L Cr
Market cap
₹1.12L Cr
₹10,560 Cr
Revenue
₹27,958 Cr
₹2,568 Cr
Net profit
₹5,355 Cr
0.00
Debt / equity
0.29
DIVI S LABORATORIES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 10.8 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
LUPIN LIMITED
  • + ["Company has delivered good profit growth of 37.4% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.1%"]
DIVI S LABORATORIES LTD full analysis LUPIN LIMITED full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

DIVI S LABORATORIES LTD vs LUPIN LIMITED: Share Price, Valuation & Which to Buy | DocStoX